You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Mexico Patent: 390786


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 390786

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,912,754 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
10,959,976 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
11,648,232 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX390786

Last updated: August 23, 2025


Introduction

Mexico Patent MX390786 pertains to a pharmaceutical invention filed within Mexico’s national patent system. Understanding the scope and claims of this patent is essential for stakeholders such as generic drug manufacturers, pharmaceutical companies, and legal professionals involved in intellectual property rights. This analysis dissects MX390786's scope, claims, and the broader patent landscape to evaluate its influence on market dynamics and innovation in the pharmaceutical sector.


Patent Overview and Filing Context

MX390786 was granted by the Mexican Institute of Industrial Property (IMPI). While detailed information about the actual filing date, inventor, and applicant is necessary, typical patent prosecution indicates that this patent covers a specific pharmaceutical compound or formulation. Mexican patents generally follow international standards, covering compounds, methods of use, formulations, and manufacturing processes.

Note: For exact details, consulting the IMPI patent database or official patent certificate provides specifics such as filing date, priorities, and legal status. This review assumes MX390786 is a pharmaceutical patent focused on a novel molecular entity or a method of treatment.


Scope and Claims of MX390786

1. Scope of the Patent

The scope delineates the boundaries of legal protection conferred by MX390786. In pharmaceutical patents, this scope often includes claims that define:

  • Chemical compounds: Novel molecules or derivatives.
  • Methods of synthesis: The process for producing the compound.
  • Therapeutic use: Specific medical indications or treatment methods.
  • Formulations: Compositions comprising the active ingredient.
  • Polymorphs or salts: Variants of the compound with unique properties.

The scope's breadth directly influences enforcement and the likelihood of patent infringement by competitors. A broad scope, such as covering a class of compounds or general methods, presents higher legal strength but may face challenges during patent examination for lack of inventive step or novelty. Narrow claims, e.g., specific salts or formulations, offer more targeted protection.

2. Claims Analysis

The claims are the legal backbone of the patent, specifying the features that define the invention. For MX390786, typical claims might include:

  • Primary (independent) claims: Covering the core invention, such as a particular chemical entity or a method of treatment.
  • Dependent claims: Detailing preferred embodiments, specific salts, formulations, dosages, or synthesis processes.

Sample assessment:

  • Novelty: For the patent to be granted, the claims must be novel over prior art, including existing molecules, publications, and similar patents.
  • Inventive Step: Claims should embody inventive superiority, such as improved efficacy, reduced side effects, or simplified synthesis.
  • Clarity and Enablement: The claims provide clear boundaries, supported by detailed descriptions, to enable practitioners skilled in the art to replicate the invention.

3. Claim Types and Their Implications

In pharmaceutical patents, claims often span:

  • Compound claims: Protecting the chemical entity itself.
  • Use claims: Covering medical indications, e.g., "Use of compound X for treating disease Y."
  • Process claims: Method of manufacturing or synthesis.

The scope of claims in MX390786 influences legal enforceability. Broad compound claims could prevent competitors from selling similar molecules, whereas narrow use claims might only restrict specific applications.


Patent Landscape Analysis in Mexico

The patent landscape for pharmaceutical compounds in Mexico is shaped by domestic and international patent filings, scientific innovation trends, and regulatory considerations.

1. Mexican Patent Environment

The IMPI traditionally follows the examination standards aligned with TRIPS (Trade-Related Aspects of Intellectual Property Rights). Mexican pharmaceutical patents typically face rigorous scrutiny, especially if prior art suggests similar compounds or uses.

Additionally, Mexico’s patent laws are evolving to adapt to international treaties like the Patent Cooperation Treaty (PCT), influencing patent scope and enforcement.

2. Competitor and Innovation Trends

The patent landscape around MX390786 can be mapped by analyzing:

  • Prior Art References: Patent searches reveal similar molecules or formulations registered in Mexico or internationally that could impact MX390786's validity.
  • Patent Families: Related patents filed in other jurisdictions (e.g., US, EP, PCT filings) demonstrate global strategic protection.
  • Legal Challenges: Post-grant oppositions, if any, or litigation history, may indicate the strength or vulnerabilities of MX390786.

3. Overlaps and Potential Infringements

Manufacturers working on similar chemical classes or indications should carefully analyze MX390786’s claims scope to avoid infringement. The breadth of claims can also influence licensing opportunities and market entry strategies.


Competitive Position and Strategic Implications

The patent's scope determines its competitive advantage:

  • Broad Claims: Provide extensive protection, deterring competitors from entering the space and enabling licensing deals.
  • Narrow Claims: Allow for potential design-arounds, requiring vigilant monitoring of emerging patents.
  • Patent Life: Given that the patent was likely filed a few years prior, its remaining enforceable term influences market exclusivity.

Mexican patent laws provide 20 years of protection from the filing date, with potential extensions or supplementary protections depending on regulatory approvals and patent maintenance.


Legal and Commercial Considerations

  • Patent Validity: Competitors may challenge MX390786 via non-infringement or novelty/inventive step arguments. Continuous prior art monitoring is essential.
  • Market Exclusivity: The patent Title supports exclusivity for the specific molecule or use, affecting pricing and market share.
  • Regulatory Alignment: The patent must align with regulatory authorization for commercial exploitation in Mexico, particularly with drug registration and data exclusivity.

Conclusion

Mexican Patent MX390786 likely secures a specific therapeutic compound or formulation, with claims structured to protect a unique chemical entity, its methods, or use. Its scope, characterized by the explicit language of its claims, influences its enforceability and competitive leverage. The patent landscape indicates a dynamic environment, with potential overlaps in chemical classes necessitating careful infringement and validity analysis. For patent holders and implementers, understanding MX390786's precise claims and legal standing is critical for strategic decision-making.


Key Takeaways

  • A comprehensive review of MX390786’s claims reveals whether it broadly covers classes of molecules or narrowly targets specific compounds or indications.
  • Extensive patent landscape analysis, including prior art and related family patents, helps assess strengths and vulnerabilities.
  • The scope of protection directly impacts market exclusivity, licensing potential, and risk management.
  • Stakeholders must monitor for potential challenges and expiry dates to optimize strategic planning.
  • Ongoing legal and regulatory vigilance ensures effective exploitation of the patent rights in the evolving Mexican pharmaceutical market.

FAQs

1. What is the primary focus of Mexican Patent MX390786?
It likely protects a chemical compound, a method of treatment, or a formulation related to pharmaceutical use, although specifics require review of the patent document.

2. How does the scope of claims influence patent validity?
Broader claims provide stronger protection but face higher scrutiny for novelty and inventive step; narrower claims are easier to defend but offer limited protection.

3. Can MX390786 be challenged or invalidated?
Yes, through legal procedures such as opposition or nullity actions based on prior art, obviousness, or insufficient disclosure.

4. How does the patent landscape in Mexico compare to other jurisdictions?
Mexico's patent system shares similarities with international standards but involves localized procedural nuances; patent families filed internationally expand protection scope.

5. What strategic actions should patent holders consider?
Regular patent landscape analysis, vigilant monitoring for infringements, and timely maintenance are essential for maximizing patent value and market position.


Sources:
[1] IMPI Official Patent Database
[2] Mexican Patent Law (Ley de la Propiedad Industrial)
[3] WIPO Patent Landscape Reports
[4] Global patent analysis tools and patent family databases

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.